Skip to content
10-Q

Quarterly Report

Oncolix, Inc.

0001477932-18-002413

← back to feed
Filed
May 14, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · May 14, 2018 104.48M sh
Operating Cash Flow Q1 2018 · Mar 31, 2018 −$463.98K
Operating Cash Flow restated Q1 2018 · Mar 31, 2017 −$331.43K
Cash And Equivalents Q1 2018 · Mar 31, 2018 $30.43K
Cash And Equivalents Q1 2018 · Dec 31, 2017 $494.41K
Cash And Equivalents Q1 2018 · Mar 31, 2017 $710.13K
Cash And Equivalents restated Q1 2018 · Dec 31, 2016 $15.26K
Stockholders Equity Q1 2018 · Mar 31, 2018 −$3.14M
Stockholders Equity Q1 2018 · Dec 31, 2017 −$1.64M
Current Liabilities Q1 2018 · Mar 31, 2018 $2.28M
Current Liabilities Q1 2018 · Dec 31, 2017 $1.26M
Total Liabilities Q1 2018 · Mar 31, 2018 $3.55M
Total Liabilities Q1 2018 · Dec 31, 2017 $2.53M
Current Assets Q1 2018 · Mar 31, 2018 $404.31K
Current Assets Q1 2018 · Dec 31, 2017 $889.4K
Total Assets Q1 2018 · Mar 31, 2018 $404.31K
Total Assets Q1 2018 · Dec 31, 2017 $889.4K
Sga Expense Q1 2018 · Mar 31, 2018 $295.82K
Sga Expense restated Q1 2018 · Mar 31, 2017 $234.84K
Rd Expense Q1 2018 · Mar 31, 2018 $104.32K
Rd Expense Q1 2018 · Mar 31, 2017 $50.32K
Net Income Q1 2018 · Mar 31, 2018 −$1.5M
Net Income restated Q1 2018 · Mar 31, 2017 −$466.55K